CRUCELL/AERAS START TURBERCULOSIS VACCINE CLINICAL TRIAL

Worldwide Biotech Group

首页> 外文期刊>Worldwide Biotech >CRUCELL/AERAS START TURBERCULOSIS VACCINE CLINICAL TRIAL

【24h】

CRUCELL/AERAS START TURBERCULOSIS VACCINE CLINICAL TRIAL

机译：CRUCELL公司/ AERAS开始TURBERCULOSIS疫苗临床试验

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Dutch biotechnology company Crucell N.V.(Euronext,NASDAQ:CRXL;Swiss Exchange:CRX) has started the phase I clinical trial of the AdVac-based tuberculosis vaccine it is developing in partnership with The AERAS Global TB Vaccine Foundation.

机译：荷兰生物科技公司Crucell喷嘴速度(泛欧交易所,纳斯达克:CRXL;瑞士交易所:CRX)开始的第一阶段临床试验AdVac-based结核病疫苗开发AERAS全球结核病疫苗合作的基础。

著录项

来源
《Worldwide Biotech》 |2006年第12期|3-4|共2页
作者
Worldwide Biotech Group;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
Tuberculosis Vaccines; Phase I Clinical Trials;

机译：结核病疫苗;I期临床试验;
入库时间 2023-05-31 00:01:47

相似文献

外文文献
中文文献

1. Next Steps for Efficacy Evaluation in Clinical Trials of COVID-19 Vaccines [J] . Hu-Dachuan Jiang, Li Zhang, Jing-Xin Li, 工程（英文） . 2021,第007期
2. CRUCELL/AERAS START TURBERCULOSIS VACCINE CLINICAL TRIAL [J] . Worldwide Biotech Group Worldwide Biotech . 2006,第12期

机译：CRUCELL / AERAS开始结核病疫苗临床试验
3. https://www.aott.org.tr/en/effect-of-adding-dexmedetomidine-to-intra-articular-levobupivacaine-on-postoperative-pain-following-arthroscopic-meniscus-surgery-a-prospective-double-blind-randomized-placebo-controlled-clinical-trial-137159 [J] . Onur Avci, Iclal Ozdemir Kol, Oguz Gundogdu, Acta Orthopaedica et Traumatologica Turcica . 2021,第4期

机译：https://www.aott.org.tr/en/effect-of-adding-dexmedetomidine-to-intra-articular-levobupivacaine-on-postoperative-pain-following-arthroscopic-meniscus-surgery-a-prospective-double-blind-randomized-placebo-controlled-clinical-trial-137159
4. Estimation of drug cost avoidance and pathology cost avoidance through participation in NCIC Clinical Trials Group phase III clinical trials in Canada [O] . P.A. Tang, A.E. Hay, C.J. O’Callaghan, 2016

机译：通过参加加拿大的NCIC Clinical Trials Group的III期临床试验来估算避免药品费用和避免病理费用
5. A dose-escalation clinical trial to evaluate the safety and immunogenicity of a replication-defective HIV-1 vaccine-HIVAX [O] . Tung F, Tung J, Fischl M 2012

机译：a dose-escalation clinical trial to evaluate the safety and immunogenicity of a replication-defective HIV-1 vaccine-HIVaX

CRUCELL/AERAS START TURBERCULOSIS VACCINE CLINICAL TRIAL

摘要

著录项

相似文献

相关主题

期刊订阅